Skip to main content
. 2024 Oct 8;22:428. doi: 10.1186/s12916-024-03620-8

Fig. 2.

Fig. 2

Overall survival in patients with EGFR T790M-positive tumors (efficacy set). Data cut-off: April 8, 2022. CI confidence interval, EGFR epidermal growth factor receptor, NR not reached